Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes

Kyoung Ah Kim, Min Jung Kim, Ji-Young Park, Ji Hong Shon, Young Ran Yoon, Sang Seop Lee, Kwang Hyeon Liu, Jin Ho Chun, Myung Ho Hyun, Jae Gook Shin

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The stereoselective metabolism of lansoprazole enantiomers was evaluated by incubation of human liver microsomes and cDNA-expressed cytochrome P450 (P450) enzymes to understand and predict their stereoselective disposition in humans in vivo. The intrinsic clearances (Clint) of the formation of both hydroxy and sulfone metabolites from S-lansoprazole were 4.9- and 2.4-fold higher than those from the R-form, respectively. The sums of formation Cl int of both metabolites were 13.5 and 57.3 μl/min/mg protein for R- and S-lansoprazole, respectively, suggesting that S-lansoprazole would be cleared more rapidly than the R-form. The P450 isoform selective inhibition study in liver microsomes, and the incubation study of cDNA-expressed enzymes, demonstrated that the stereoselective sulfoxidation is mediated by CYP3A4 and that the hydroxylation is mediated by CYP2C9 and CYP3A4 as well as by CYP2C19. Total Clint values of hydroxy and sulfone metabolite formation catalyzed by all these P450 enzymes were consistently higher for S-lansoprazole than for the R-form. The CYP3A4 produced the greatest difference of Cl int between S- and R-enantiomers, mainly due to a difference of sulfoxidation metabolism (Clint 76.5 versus 10.8 μl/min/nmol of P450, respectively), whereas CYP2C19-catalyzed hydroxylation resulted in a minor difference of Clint between S- and R-enantiomers (179.6 versus 143.3 μl/min/nmol of P450, respectively). However, the affinity of CYP2C19 on hydroxylation was 5.7-fold higher for S-enantiomer than for the R-form (Km 2.3 versus 13.1 μM), suggesting that the role of CYP2C19 on stereoselective hydroxylation would be more prominent at concentrations around the usual therapeutic level. These findings suggest that both CYP2C19 and CYP3A4 are major enzymes contributing to the stereoselective disposition of lansoprazole, but stereoselective hydroxylation of lansoprazole enantiomers is mainly influenced by CYP2C19, especially at the usual therapeutic doses.

Original languageEnglish
Pages (from-to)1227-1234
Number of pages8
JournalDrug Metabolism and Disposition
Volume31
Issue number10
DOIs
Publication statusPublished - 2003 Oct 1
Externally publishedYes

Fingerprint

Lansoprazole
Cytochrome P-450 Enzyme System
Hydroxylation
Cytochrome P-450 CYP3A
Dexlansoprazole
Liver
Sulfones
Liver Microsomes
Complementary DNA
Protein S
Enzymes
Cytochrome P-450 CYP2C19
Protein Isoforms
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Kim, K. A., Kim, M. J., Park, J-Y., Shon, J. H., Yoon, Y. R., Lee, S. S., ... Shin, J. G. (2003). Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes. Drug Metabolism and Disposition, 31(10), 1227-1234. https://doi.org/10.1124/dmd.31.10.1227

Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes. / Kim, Kyoung Ah; Kim, Min Jung; Park, Ji-Young; Shon, Ji Hong; Yoon, Young Ran; Lee, Sang Seop; Liu, Kwang Hyeon; Chun, Jin Ho; Hyun, Myung Ho; Shin, Jae Gook.

In: Drug Metabolism and Disposition, Vol. 31, No. 10, 01.10.2003, p. 1227-1234.

Research output: Contribution to journalArticle

Kim, KA, Kim, MJ, Park, J-Y, Shon, JH, Yoon, YR, Lee, SS, Liu, KH, Chun, JH, Hyun, MH & Shin, JG 2003, 'Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes', Drug Metabolism and Disposition, vol. 31, no. 10, pp. 1227-1234. https://doi.org/10.1124/dmd.31.10.1227
Kim, Kyoung Ah ; Kim, Min Jung ; Park, Ji-Young ; Shon, Ji Hong ; Yoon, Young Ran ; Lee, Sang Seop ; Liu, Kwang Hyeon ; Chun, Jin Ho ; Hyun, Myung Ho ; Shin, Jae Gook. / Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes. In: Drug Metabolism and Disposition. 2003 ; Vol. 31, No. 10. pp. 1227-1234.
@article{f24742830f1b486eb5297156b8bdab82,
title = "Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes",
abstract = "The stereoselective metabolism of lansoprazole enantiomers was evaluated by incubation of human liver microsomes and cDNA-expressed cytochrome P450 (P450) enzymes to understand and predict their stereoselective disposition in humans in vivo. The intrinsic clearances (Clint) of the formation of both hydroxy and sulfone metabolites from S-lansoprazole were 4.9- and 2.4-fold higher than those from the R-form, respectively. The sums of formation Cl int of both metabolites were 13.5 and 57.3 μl/min/mg protein for R- and S-lansoprazole, respectively, suggesting that S-lansoprazole would be cleared more rapidly than the R-form. The P450 isoform selective inhibition study in liver microsomes, and the incubation study of cDNA-expressed enzymes, demonstrated that the stereoselective sulfoxidation is mediated by CYP3A4 and that the hydroxylation is mediated by CYP2C9 and CYP3A4 as well as by CYP2C19. Total Clint values of hydroxy and sulfone metabolite formation catalyzed by all these P450 enzymes were consistently higher for S-lansoprazole than for the R-form. The CYP3A4 produced the greatest difference of Cl int between S- and R-enantiomers, mainly due to a difference of sulfoxidation metabolism (Clint 76.5 versus 10.8 μl/min/nmol of P450, respectively), whereas CYP2C19-catalyzed hydroxylation resulted in a minor difference of Clint between S- and R-enantiomers (179.6 versus 143.3 μl/min/nmol of P450, respectively). However, the affinity of CYP2C19 on hydroxylation was 5.7-fold higher for S-enantiomer than for the R-form (Km 2.3 versus 13.1 μM), suggesting that the role of CYP2C19 on stereoselective hydroxylation would be more prominent at concentrations around the usual therapeutic level. These findings suggest that both CYP2C19 and CYP3A4 are major enzymes contributing to the stereoselective disposition of lansoprazole, but stereoselective hydroxylation of lansoprazole enantiomers is mainly influenced by CYP2C19, especially at the usual therapeutic doses.",
author = "Kim, {Kyoung Ah} and Kim, {Min Jung} and Ji-Young Park and Shon, {Ji Hong} and Yoon, {Young Ran} and Lee, {Sang Seop} and Liu, {Kwang Hyeon} and Chun, {Jin Ho} and Hyun, {Myung Ho} and Shin, {Jae Gook}",
year = "2003",
month = "10",
day = "1",
doi = "10.1124/dmd.31.10.1227",
language = "English",
volume = "31",
pages = "1227--1234",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "10",

}

TY - JOUR

T1 - Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes

AU - Kim, Kyoung Ah

AU - Kim, Min Jung

AU - Park, Ji-Young

AU - Shon, Ji Hong

AU - Yoon, Young Ran

AU - Lee, Sang Seop

AU - Liu, Kwang Hyeon

AU - Chun, Jin Ho

AU - Hyun, Myung Ho

AU - Shin, Jae Gook

PY - 2003/10/1

Y1 - 2003/10/1

N2 - The stereoselective metabolism of lansoprazole enantiomers was evaluated by incubation of human liver microsomes and cDNA-expressed cytochrome P450 (P450) enzymes to understand and predict their stereoselective disposition in humans in vivo. The intrinsic clearances (Clint) of the formation of both hydroxy and sulfone metabolites from S-lansoprazole were 4.9- and 2.4-fold higher than those from the R-form, respectively. The sums of formation Cl int of both metabolites were 13.5 and 57.3 μl/min/mg protein for R- and S-lansoprazole, respectively, suggesting that S-lansoprazole would be cleared more rapidly than the R-form. The P450 isoform selective inhibition study in liver microsomes, and the incubation study of cDNA-expressed enzymes, demonstrated that the stereoselective sulfoxidation is mediated by CYP3A4 and that the hydroxylation is mediated by CYP2C9 and CYP3A4 as well as by CYP2C19. Total Clint values of hydroxy and sulfone metabolite formation catalyzed by all these P450 enzymes were consistently higher for S-lansoprazole than for the R-form. The CYP3A4 produced the greatest difference of Cl int between S- and R-enantiomers, mainly due to a difference of sulfoxidation metabolism (Clint 76.5 versus 10.8 μl/min/nmol of P450, respectively), whereas CYP2C19-catalyzed hydroxylation resulted in a minor difference of Clint between S- and R-enantiomers (179.6 versus 143.3 μl/min/nmol of P450, respectively). However, the affinity of CYP2C19 on hydroxylation was 5.7-fold higher for S-enantiomer than for the R-form (Km 2.3 versus 13.1 μM), suggesting that the role of CYP2C19 on stereoselective hydroxylation would be more prominent at concentrations around the usual therapeutic level. These findings suggest that both CYP2C19 and CYP3A4 are major enzymes contributing to the stereoselective disposition of lansoprazole, but stereoselective hydroxylation of lansoprazole enantiomers is mainly influenced by CYP2C19, especially at the usual therapeutic doses.

AB - The stereoselective metabolism of lansoprazole enantiomers was evaluated by incubation of human liver microsomes and cDNA-expressed cytochrome P450 (P450) enzymes to understand and predict their stereoselective disposition in humans in vivo. The intrinsic clearances (Clint) of the formation of both hydroxy and sulfone metabolites from S-lansoprazole were 4.9- and 2.4-fold higher than those from the R-form, respectively. The sums of formation Cl int of both metabolites were 13.5 and 57.3 μl/min/mg protein for R- and S-lansoprazole, respectively, suggesting that S-lansoprazole would be cleared more rapidly than the R-form. The P450 isoform selective inhibition study in liver microsomes, and the incubation study of cDNA-expressed enzymes, demonstrated that the stereoselective sulfoxidation is mediated by CYP3A4 and that the hydroxylation is mediated by CYP2C9 and CYP3A4 as well as by CYP2C19. Total Clint values of hydroxy and sulfone metabolite formation catalyzed by all these P450 enzymes were consistently higher for S-lansoprazole than for the R-form. The CYP3A4 produced the greatest difference of Cl int between S- and R-enantiomers, mainly due to a difference of sulfoxidation metabolism (Clint 76.5 versus 10.8 μl/min/nmol of P450, respectively), whereas CYP2C19-catalyzed hydroxylation resulted in a minor difference of Clint between S- and R-enantiomers (179.6 versus 143.3 μl/min/nmol of P450, respectively). However, the affinity of CYP2C19 on hydroxylation was 5.7-fold higher for S-enantiomer than for the R-form (Km 2.3 versus 13.1 μM), suggesting that the role of CYP2C19 on stereoselective hydroxylation would be more prominent at concentrations around the usual therapeutic level. These findings suggest that both CYP2C19 and CYP3A4 are major enzymes contributing to the stereoselective disposition of lansoprazole, but stereoselective hydroxylation of lansoprazole enantiomers is mainly influenced by CYP2C19, especially at the usual therapeutic doses.

UR - http://www.scopus.com/inward/record.url?scp=10744225323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744225323&partnerID=8YFLogxK

U2 - 10.1124/dmd.31.10.1227

DO - 10.1124/dmd.31.10.1227

M3 - Article

VL - 31

SP - 1227

EP - 1234

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 10

ER -